Article(id=1325193768365862980, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193394649178885, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.06.009, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1767715200000, receivedDateStr=2026-01-07, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793880415288, onlineDateStr=2026-11-05, pubDate=1781020800000, pubDateStr=2026-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793880415288, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793880415288, creator=13701087609, updateTime=1793880415288, updator=13701087609, issue=Issue{id=1325193394649178885, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='6', pageStart='625', pageEnd='742', issueExtLink='null', onlineDate='null', pubDate='1781020800000', pubDateStr='2026-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793880326187, creator='13701087609', updateTime=1793935314652, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325424033046606126, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193394649178885, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325424033046606127, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193394649178885, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=685, endPage=691, ext={EN=ArticleExt(id=1325193768609132613, articleId=1325193768365862980, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Preparation and Pharmacodynamic Evaluation of Upadacitinib Cream for Atopic Dermatitis, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

The formulation of upadacitinib(1) cream was investigated by a single-factor experiment, and its skin retention and permeation of 1 from the optimal cream were evaluated using Bama miniature pig skin as a model.Furthermore, its pharmacodynamic effects on mice with atopic dermatitis were also examined. The composition of the final optimized formulation was as follows: 2.0% of 1, 10.0% of white petrolatum, 10.0% of phosphate ester self-emulsifying wax, 5.0% of isopropyl palmitate, 20.0% of diethylene glycol monoethyl ether, 4.0% of 1,2-propylene glycol,0.2% of methylparaben, 0.05% of propylparaben, and 0.05% of EDTA-2Na. Stability study results showed that the cream formulations with drug loadings of 0.6% and 2.0% met the requirements for content, related substances, and physical form after 6 months of accelerated testing, demonstrating good stability. In vivo pharmacodynamic results demonstrated that the cream was superior to betamethasone cream in reducing ear swelling and alleviating skin lesions in mice. The formulation and manufacturing process were stable and controllable, and the product had a favorable efficacy, providing a basis for the development and application of 1 as a topical formulation.

, authors=Changjun LI1, Lele HUANG2, Wenhua LI1, *, authorsList=Changjun LI, Lele HUANG, Wenhua LI, authorCompany=null, correspAuthors=Wenhua LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325193768839819334, articleId=1325193768365862980, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=乌帕替尼乳膏的研制及其对特应性皮炎的药效学评价, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

采用单因素试验优化乌帕替尼(1)乳膏处方,以巴马小型猪皮肤为模型考察1乳膏的皮内滞留率和渗透率,并考察其对特应性皮炎小鼠的药效。最终优化处方中各组分的质量分数为:12.0%、白凡士林10.0%、磷酸酯自乳化蜡10.0%、棕榈酸异丙酯5.0%、二乙二醇单乙醚20.0%、1,2-丙二醇4.0%、羟苯甲酯0.2%、羟苯丙酯0.05%、EDTA-2Na 0.05%。稳定性研究结果表明,载药量为0.6%和2.0%的1乳膏,在加速试验6个月的条件下,含量、有关物质、物理形态等均满足要求,稳定性良好。体内药效学研究结果表明,1乳膏在改善小鼠耳廓肿胀和皮肤病变方面的效果均优于倍他米松乳膏。该乳膏处方工艺稳定、可控,药效良好,可为1外用制剂的开发和应用提供参考。

, authors=李长军1, 黄乐乐2, 李文华1, *, authorsList=李长军, 黄乐乐, 李文华, authorCompany=null, correspAuthors=李文华, authorNote=

李长军,工程师,硕士,从事药物制剂研发工作。

, correspAuthorsNote=
李文华,高级工程师,博士,从事药物研发工作。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=tsPrp2zuYCzzF7dWdXDfuw==, magXml=EgCljEBq9tGD0xYlTR4QlA==, pdfUrl=null, pdf=rlDtMK6nnu3XfaPCEcslow==, pdfFileSize=1499135, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Wctjk4VR/MTR3qXaY2Dklg==, mapNumber=null, fund=null)}, authors=[Author(id=1325193769238278222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193769313775696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769238278222, language=EN, stringName=Changjun LI, firstName=Changjun, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193769380884561, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769238278222, language=CN, stringName=李长军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海汇伦医药股份有限公司,上海 201108, bio={"content":"

李长军,工程师,硕士,从事药物制剂研发工作。

"}, bioImg=null, bioContent=

李长军,工程师,硕士,从事药物制剂研发工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769028563015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=1., ext=[AuthorCompanyExt(id=1325193769041145928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108), AuthorCompanyExt(id=1325193769049534537, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海汇伦医药股份有限公司,上海 201108)])]), Author(id=1325193769456382035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193769540268117, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769456382035, language=EN, stringName=Lele HUANG, firstName=Lele, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193769624154198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769456382035, language=CN, stringName=黄乐乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769146003530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=2., ext=[AuthorCompanyExt(id=1325193769154392139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193769162780748, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1325193769712234584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325193771389956186, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769712234584, language=EN, stringName=Wenhua LI, firstName=Wenhua, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193771503202395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769712234584, language=CN, stringName=李文华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海汇伦医药股份有限公司,上海 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769028563015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=1., ext=[AuthorCompanyExt(id=1325193769041145928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108), AuthorCompanyExt(id=1325193769049534537, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海汇伦医药股份有限公司,上海 201108)])])], keywords=[Keyword(id=1325193771637420124, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=1, keyword=upadacitinib), Keyword(id=1325193771763249245, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=2, keyword=atopic dermatitis), Keyword(id=1325193771842941022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=3, keyword=cream), Keyword(id=1325193771914244191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=4, keyword=formulation optimization), Keyword(id=1325193771977158752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=5, keyword=in vitro permeation), Keyword(id=1325193772048461921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=EN, orderNo=6, keyword=pharmacodynamics), Keyword(id=1325193772132348002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=1, keyword=乌帕替尼), Keyword(id=1325193772199456867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=2, keyword=特应性皮炎), Keyword(id=1325193772274954340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=3, keyword=乳膏), Keyword(id=1325193772392394853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=4, keyword=处方优化), Keyword(id=1325193772455309414, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=5, keyword=体外渗透性), Keyword(id=1325193772539195495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, language=CN, orderNo=6, keyword=药效学)], refs=[Reference(id=1325193772832796776, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等.特应性皮炎基层诊疗指南(2022年)[J].中华全科医师杂志, 2022, 21(7): 609-619., articleTitle=null, refAbstract=null), Reference(id=1325193772933460073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心.中国特应性皮炎诊疗指南(2020版)[J].中华皮肤科杂志, 2020, 53(2): 81-88., articleTitle=null, refAbstract=null), Reference(id=1325193773252227178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=王奕恒, 陈文琦.阿布昔替尼对中重度特应性皮炎患者的疗效及对皮肤屏障功能的影响研究[J].世界临床药物,2026, 47(3): 273-279., articleTitle=null, refAbstract=null), Reference(id=1325193773352890475, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=BLAUVELT A, TEIXEIRA H D, SIMPSON E L, et al.Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial [J].JAMA Dermatol, 2021, 157(9): 1047-1055., articleTitle=null, refAbstract=null), Reference(id=1325193773466136684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=VIRTANEN A, SPINELLI F R, TELLIEZ J B, et al.JAK inhibitor selectivity: new opportunities, better drugs? [J].Nat Rev Rheumatol, 2024, 20(10): 649-665., articleTitle=null, refAbstract=null), Reference(id=1325193773545828461, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.RINVOQ: product quality review [EB/OL].[2019-09-12].https: //www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211675Orig1s000ChemR.pdf., articleTitle=null, refAbstract=null), Reference(id=1325193773659074670, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SANTOS L L, SWOFFORD N J, SANTIAGO B G.In vitro permeation test(IVPT) for pharmacokinetic assessment of topical dermatological formulations [J].Curr Protoc Pharmacol, 2020, 91(1): e79., articleTitle=null, refAbstract=null), Reference(id=1325193773742960751, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=毛可阳, 朱慧勇, 罗华菲, 等.皮肤外用制剂物理化学和结构特性表征的要求概述[J].中国医药工业杂志, 2025,56(3): 293-302., articleTitle=null, refAbstract=null), Reference(id=1325193773826846832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=晏娜, 汤湛, 往俏.阿魏酸乳膏的体外经皮渗透性及大鼠体内药动学 [J].中国医药工业杂志, 2025, 56(1): 73-79., articleTitle=null, refAbstract=null), Reference(id=1325193773906538609, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FLATEN G E, PALAC Z, ENGESLAND A, et al.In vitro skin models as a tool in optimization of drug formulation [J].Eur J Pharm Sci, 2015, 75: 10-24., articleTitle=null, refAbstract=null), Reference(id=1325193773994618994, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=PERSAUD I, DIAMOND S, PAN R, et al.Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs [J].Int J Pharm, 2020, 590: 119889., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325193769028563015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=1., ext=[AuthorCompanyExt(id=1325193769041145928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108), AuthorCompanyExt(id=1325193769049534537, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海汇伦医药股份有限公司,上海 201108)]), AuthorCompany(id=1325193769146003530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=2., ext=[AuthorCompanyExt(id=1325193769154392139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193769162780748, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.06.009, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.06.009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.06.009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.06.009, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1781020800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
乌帕替尼乳膏的研制及其对特应性皮炎的药效学评价
李长军 1 , 黄乐乐 2 , 李文华 1, *
中国医药工业杂志 | 研究论文 2026,57(6): 685-691
收起
收藏切换
中国医药工业杂志 |研究论文 2026 , 57 (6) : 685 -691
乌帕替尼乳膏的研制及其对特应性皮炎的药效学评价
全屏
[Author(id=1325193769238278222, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193769313775696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769238278222, language=EN, stringName=Changjun LI, firstName=Changjun, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193769380884561, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769238278222, language=CN, stringName=李长军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海汇伦医药股份有限公司,上海 201108, bio={"content":"

李长军,工程师,硕士,从事药物制剂研发工作。

"}, bioImg=null, bioContent=

李长军,工程师,硕士,从事药物制剂研发工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769028563015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=1., ext=[AuthorCompanyExt(id=1325193769041145928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108), AuthorCompanyExt(id=1325193769049534537, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海汇伦医药股份有限公司,上海 201108)])]), Author(id=1325193769456382035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193769540268117, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769456382035, language=EN, stringName=Lele HUANG, firstName=Lele, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193769624154198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769456382035, language=CN, stringName=黄乐乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769146003530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=2., ext=[AuthorCompanyExt(id=1325193769154392139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193769162780748, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769146003530, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1325193769712234584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325193771389956186, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769712234584, language=EN, stringName=Wenhua LI, firstName=Wenhua, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193771503202395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, authorId=1325193769712234584, language=CN, stringName=李文华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海汇伦医药股份有限公司,上海 201108, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193769028563015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, xref=1., ext=[AuthorCompanyExt(id=1325193769041145928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108), AuthorCompanyExt(id=1325193769049534537, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193768365862980, companyId=1325193769028563015, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海汇伦医药股份有限公司,上海 201108)])])]
李长军1, 黄乐乐2, 李文华1, *
作者信息
  • 1.上海汇伦医药股份有限公司,上海 201108
  • 2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203
通讯作者:
李文华,高级工程师,博士,从事药物研发工作。
作者简介:

李长军,工程师,硕士,从事药物制剂研发工作。

Preparation and Pharmacodynamic Evaluation of Upadacitinib Cream for Atopic Dermatitis
Changjun LI1, Lele HUANG2, Wenhua LI1, *
Affiliations
  • 1.Shanghai Huilun Pharmaceutical Co., Ltd., Shanghai 201108
  • 2.National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2026-06-10 doi: 10.16522/j.cnki.cjph.2026.06.009
文章导航
收藏切换

采用单因素试验优化乌帕替尼(1)乳膏处方,以巴马小型猪皮肤为模型考察1乳膏的皮内滞留率和渗透率,并考察其对特应性皮炎小鼠的药效。最终优化处方中各组分的质量分数为:12.0%、白凡士林10.0%、磷酸酯自乳化蜡10.0%、棕榈酸异丙酯5.0%、二乙二醇单乙醚20.0%、1,2-丙二醇4.0%、羟苯甲酯0.2%、羟苯丙酯0.05%、EDTA-2Na 0.05%。稳定性研究结果表明,载药量为0.6%和2.0%的1乳膏,在加速试验6个月的条件下,含量、有关物质、物理形态等均满足要求,稳定性良好。体内药效学研究结果表明,1乳膏在改善小鼠耳廓肿胀和皮肤病变方面的效果均优于倍他米松乳膏。该乳膏处方工艺稳定、可控,药效良好,可为1外用制剂的开发和应用提供参考。

乌帕替尼  /  特应性皮炎  /  乳膏  /  处方优化  /  体外渗透性  /  药效学

The formulation of upadacitinib(1) cream was investigated by a single-factor experiment, and its skin retention and permeation of 1 from the optimal cream were evaluated using Bama miniature pig skin as a model.Furthermore, its pharmacodynamic effects on mice with atopic dermatitis were also examined. The composition of the final optimized formulation was as follows: 2.0% of 1, 10.0% of white petrolatum, 10.0% of phosphate ester self-emulsifying wax, 5.0% of isopropyl palmitate, 20.0% of diethylene glycol monoethyl ether, 4.0% of 1,2-propylene glycol,0.2% of methylparaben, 0.05% of propylparaben, and 0.05% of EDTA-2Na. Stability study results showed that the cream formulations with drug loadings of 0.6% and 2.0% met the requirements for content, related substances, and physical form after 6 months of accelerated testing, demonstrating good stability. In vivo pharmacodynamic results demonstrated that the cream was superior to betamethasone cream in reducing ear swelling and alleviating skin lesions in mice. The formulation and manufacturing process were stable and controllable, and the product had a favorable efficacy, providing a basis for the development and application of 1 as a topical formulation.

upadacitinib  /  atopic dermatitis  /  cream  /  formulation optimization  /  in vitro permeation  /  pharmacodynamics
李长军, 黄乐乐, 李文华. 乌帕替尼乳膏的研制及其对特应性皮炎的药效学评价. 中国医药工业杂志, 2026 , 57 (6) : 685 -691 . DOI: 10.16522/j.cnki.cjph.2026.06.009
Changjun LI, Lele HUANG, Wenhua LI. Preparation and Pharmacodynamic Evaluation of Upadacitinib Cream for Atopic Dermatitis[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (6) : 685 -691 . DOI: 10.16522/j.cnki.cjph.2026.06.009

参考文献 引证文献
排序方式:
[1]
中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等.特应性皮炎基层诊疗指南(2022年)[J].中华全科医师杂志, 2022, 21(7): 609-619.
[2]
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心.中国特应性皮炎诊疗指南(2020版)[J].中华皮肤科杂志, 2020, 53(2): 81-88.
[3]
王奕恒, 陈文琦.阿布昔替尼对中重度特应性皮炎患者的疗效及对皮肤屏障功能的影响研究[J].世界临床药物,2026, 47(3): 273-279.
[4]
BLAUVELT A, TEIXEIRA H D, SIMPSON E L, et al.Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial [J].JAMA Dermatol, 2021, 157(9): 1047-1055.
[5]
VIRTANEN A, SPINELLI F R, TELLIEZ J B, et al.JAK inhibitor selectivity: new opportunities, better drugs? [J].Nat Rev Rheumatol, 2024, 20(10): 649-665.
[6]
FDA.RINVOQ: product quality review [EB/OL].[2019-09-12].https: //www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211675Orig1s000ChemR.pdf.
[7]
SANTOS L L, SWOFFORD N J, SANTIAGO B G.In vitro permeation test(IVPT) for pharmacokinetic assessment of topical dermatological formulations [J].Curr Protoc Pharmacol, 2020, 91(1): e79.
[8]
毛可阳, 朱慧勇, 罗华菲, 等.皮肤外用制剂物理化学和结构特性表征的要求概述[J].中国医药工业杂志, 2025,56(3): 293-302.
[9]
晏娜, 汤湛, 往俏.阿魏酸乳膏的体外经皮渗透性及大鼠体内药动学 [J].中国医药工业杂志, 2025, 56(1): 73-79.
[10]
FLATEN G E, PALAC Z, ENGESLAND A, et al.In vitro skin models as a tool in optimization of drug formulation [J].Eur J Pharm Sci, 2015, 75: 10-24.
[11]
PERSAUD I, DIAMOND S, PAN R, et al.Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs [J].Int J Pharm, 2020, 590: 119889.
2026年第57卷第6期
148
45
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.06.009
  • 接收时间:2026-01-07
  • 首发时间:2026-11-05
  • 出版时间:2026-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-01-07
基金
作者信息
    1.上海汇伦医药股份有限公司,上海 201108
    2.中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203

通讯作者:

李文华,高级工程师,博士,从事药物研发工作。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.06.009
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏